Skip to main content
Cannovum Cannabis AG logo

Cannovum Cannabis AG — Investor Relations & Filings

Ticker · 27N0 ISIN · DE000A37FUP2 LEI · 894500IT61F9P85YMM31 DU Manufacturing
Open in API
Filings indexed 43 across all filing types
Latest filing 2025-02-27 Delisting Announcement
Country DE Germany
Listing DU 27N0

About Cannovum Cannabis AG

https://www.cannovum.de/

Cannovum Cannabis AG is a pharmaceutical company that operates as a licensed importer, wholesaler, and manufacturer of high-quality medical cannabis products. The company's primary focus is on supplying the medical market and providing patients with therapeutic options. In response to evolving regulations, Cannovum is also strategically positioning itself for the legalized recreational cannabis market. This includes initiatives aimed at public education and brand awareness, alongside developing a product portfolio for the adult-use consumer segment. The company is also engaged in expanding its operations into other European markets.

Recent filings

Filing Released Lang Actions
Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector
Delisting Announcement Classification · 1% confidence The document is a short corporate news release dated February 26, 2025, announcing strategic decisions, specifically the liquidation of one investment and the planned sale of another, due to political uncertainty regarding cannabis legalization. It also mentions that the Management Board will propose a name change at the upcoming Annual General Meeting (AGM) in August. Since this is a brief announcement of corporate actions and strategic changes, and it is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal proxy statement (PSI), it fits best under the general category for corporate news that doesn't fit elsewhere, or potentially a strategic update. Given the options, it is a general corporate announcement disseminated via EQS News. It is too specific for the general 'RNS' fallback, but it details strategic decisions and mentions an upcoming AGM proposal. However, it is primarily a strategic update regarding business direction and asset disposal. Since there is no specific code for 'Strategic Update,' and it is not a formal regulatory filing like a 10-K or a specific report like AR or IR, the most appropriate classification among the provided options for a general, non-financial-result-focused corporate announcement is 'Regulatory Filings' (RNS) as a catch-all for miscellaneous corporate news, or potentially 'TAR' if the sale/liquidation were framed as M&A, which it is not. Given the content focuses on internal strategic decisions and liquidation plans, and it is a short news item, 'RNS' (Regulatory Filings/Miscellaneous Announcement) is the safest general classification, as it is a standard news dissemination format (EQS News). It is not a DVA (Voting Results), AGM-R (Meeting Material), or ER (Earnings Release).
2025-02-27 English
Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector
Delisting Announcement Classification · 1% confidence The document is a short corporate news release dated February 26, 2025, announcing strategic decisions, specifically the liquidation of one investment and the planned sale of another, due to political uncertainty regarding cannabis legalization. It also mentions that the Management Board will propose a name change at the upcoming Annual General Meeting (AGM) in August. Since this is a brief announcement of corporate actions and strategic changes, and it is not a full financial report (like 10-K or IR), nor is it a transcript (CT) or a formal proxy statement (PSI), it fits best under the general category for corporate news that doesn't fit elsewhere, or potentially a strategic update. Given the options, it is a general corporate announcement disseminated via EQS News. It is too specific for the general 'RNS' fallback, but it details strategic decisions and mentions an upcoming AGM proposal. However, it is primarily a strategic update regarding business direction and asset disposal. Since there is no specific code for 'Strategic Update,' and it is not a formal regulatory filing like a 10-K or a specific report like AR or IR, the most appropriate classification among the provided options for a general, non-financial-result-focused corporate announcement is 'Regulatory Filings' (RNS) as a catch-all for miscellaneous corporate news, or potentially 'TAR' if the sale/liquidation were framed as M&A, which it is not. Given the content focuses on internal strategic decisions and liquidation plans, and it is a short news item, 'RNS' (Regulatory Filings/Miscellaneous Announcement) is the safest general classification, as it is a standard news dissemination format (EQS News). It is not a DVA (Voting Results), AGM-R (Meeting Material), or ER (Earnings Release).
2025-02-26 English
Cannovum Cannabis AG: Far-reaching partnership with H.i. Greeny+ GmbH and H.i Competence Group for cannabis legalisation
Regulatory Filings Classification · 1% confidence The document is a news release disseminated via EQS-News, dated August 1, 2024, announcing a 'Far-reaching partnership' between Cannovum Cannabis AG and H.i. Greeny+ GmbH/H.i Competence Group regarding cannabis legalization opportunities. The content focuses on strategic corporate decisions, joint ventures, and future business plans, rather than specific financial results (ER/IR), regulatory filings (10-K/AR), or shareholder voting (DVA/DEF 14A). Since it announces a significant strategic development and is distributed as a general corporate news item, it fits best under the general Regulatory Filings/News category (RNS), as it is not explicitly defined as an Earnings Release (ER) or a specific financing/M&A event, but rather a general corporate update. However, given the nature of the announcement (a major strategic partnership/joint venture), it is a significant corporate event. If a more specific category existed for 'Strategic Partnership Announcement', that would be ideal. Among the provided options, RNS serves as the best general regulatory/news announcement fallback for significant, non-financial-reporting corporate news that doesn't fit other specific categories like DIV, CAP, or TAR. The document length (6003 chars) is substantial enough that it is not merely an RPA announcing a report.
2024-08-01 English
Cannovum Cannabis AG: 'Cannabis for Germany', sale of fake hemp in 1,000 Aldi Sud stores starts on 27 June
Regulatory Filings Classification · 1% confidence The document is a news release dated June 26, 2024, announcing a product launch ('fake hemp') in Aldi Süd stores starting June 27, 2024, and discussing future plans related to cannabis legalization and club support. It uses the EQS-News format and contains keywords like 'Product Launch/Alliance' and 'Corporate News'. This type of announcement, detailing a specific business event (product sale/marketing campaign) that is not a formal financial report (like 10-K or IR) or a management change, typically falls under general regulatory announcements or news releases. Since it is not a formal financial report, an earnings release (ER), or a specific corporate action like a dividend (DIV) or share issue (SHA), the most appropriate general category for a significant, non-financial-results-focused corporate update distributed via a news service is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory announcements not covered by other specific codes. Given the short length and the nature of the announcement (a news detail), it is not the full report itself.
2024-06-26 English
Cannovum Cannabis AG: Bundestag confirms Cannovum Cannabis AG's business model for cultivation clubs, legal certainty for recreational cannabis producers
Legal Proceedings Report Classification · 1% confidence The document is a short news release dated June 7, 2024, disseminated via EQS News. It announces that the Bundestag confirmed the business model for cultivation clubs under the new Cannabis Act (CanG), providing legal certainty for Cannovum Cannabis AG's operations. This is a general corporate announcement regarding market developments and regulatory changes impacting the business, rather than a formal financial report (like 10-K, IR, ER) or a specific transaction report (like DIV, DIRS, CAP). Since it is a general corporate news item distributed through a regulatory news service (EQS), and it doesn't fit into the more specific categories like Earnings Release (ER) or Management Discussion (MDA), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere, or potentially a general news release. Given the context of 'EQS-News' and the nature of the announcement (a company commenting on new legislation), RNS is the best fit among the provided options for a general, non-financial, non-meeting related corporate update.
2024-06-07 English
Cannovum Cannabis AG: Cash capital increase from authorized capital with subscription rights
Share Issue/Capital Change Classification · 1% confidence The document is an 'Ad-hoc' announcement dated June 4, 2024, disclosing an 'Inside Information' pursuant to Article 17 MAR. The core content details the Management Board's resolution to execute a 'Cash capital increase from authorized capital with subscription rights' by issuing new shares. This action directly relates to changes in the company's capital structure and fundraising activities. Based on the provided definitions, this fits best under 'Capital/Financing Update' (CAP), as it announces the issuance of new shares for financing operations and liability reduction.
2024-06-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.